Wenjing Gu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital · ORCID：0000-0003-1604-7666

发表论文 34 篇 · 总被引 131 次 · h-index 6

代表论文

• A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia (2024 · New England Journal of Medicine · 被引 48)
• Prediction of thrombosis in polycythemia vera: Development and validation of a multiple factor-based prognostic score system (2023 · Research and Practice in Thrombosis and Haemostasis · 被引 19)
• Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial (2025 · BMJ · 被引 6)
• Artificial intelligence-based quantitative bone marrow pathology analysis for myeloproliferative neoplasms (2025 · Haematologica · 被引 6)
• Childhood and adolescent essential thrombocythemia and prefibrotic primary myelofibrosis: insights into diagnosis, outcomes, and treatment from a large Chinese cohort (2024 · Leukemia · 被引 4)
• Kabuki syndrome complicated by severe immune thrombocytopenia and autoimmune thyroiditis: Identification of a novel pathogenic mutation (2024 · British Journal of Haematology · 被引 3)